/ENBI.CN
ENBI.CN Stock - Entheon Biomedical Corp.
Healthcare|BiotechnologyCNQ
$0.10+0.00%
+$0.00 (+0.00%) • Dec 18
62
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.62
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.62
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.11
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ENBI.CN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.10 – $0.10
TARGET (TP)$0.11
STOP LOSS$0.09
RISK/REWARD1:1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.44
52W High$0.45
52W Low$0.07
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | $250,323 | $189,677 | $21,670 | N/A |
| Gross Profit | N/A | $250,323 | $189,677 | $9,130 | $-2,724 |
| Gross Margin | N/A | 100.0% | 100.0% | 42.1% | N/A |
| Operating Income | $-333,000 | $-313,000 | $-3,600,000 | $-8,211,000 | $-1,649,132 |
| Net Income | $-318,000 | $-300,000 | $-8,521,000 | $-8,887,000 | $-4,378,032 |
| Net Margin | N/A | -119.8% | -4492.4% | -41010.6% | N/A |
| EPS | $-0.04 | $-0.05 | $-0.14 | $-0.16 | $-1.60 |
Company Overview
Entheon Biomedical Corp. operates as a biotechnology research and drug development company. It engages in developing and commercializing various N,N-dimethyltryptamine based psychedelic therapeutic products for treating addiction and substance use disorders. The company serves physicians, clinics, and licensed psychiatrists in Canada, the United States, and European Union. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ENBI.CNBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q4 2025
EPS Surprise History
Q4 23
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q4 24
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 30, 2026 | — | — | — | — |
Q4 2025 | Oct 22, 2025 | — | $-0.00 | — | — |
Q3 2025 | Jul 2, 2025 | — | $-0.00 | — | — |
Q2 2025 | Apr 1, 2025 | — | $-0.01 | — | — |
Q4 2024 | Dec 27, 2024 | — | $-0.01 | — | — |
Q4 2024 | Oct 24, 2024 | — | $-0.01 | — | — |
Q3 2024 | Jul 4, 2024 | — | $-0.01 | — | — |
Q2 2024 | Apr 29, 2024 | — | $-0.01 | — | — |
Q4 2023 | Dec 29, 2023 | — | $-0.01 | — | — |
Q4 2023 | Oct 25, 2023 | — | $-0.02 | — | — |
Q3 2023 | Jul 26, 2023 | — | $-0.01 | — | — |
Q2 2023 | Apr 28, 2023 | — | $-0.00 | — | — |
Q1 2023 | Mar 23, 2023 | — | $-0.10 | — | — |
Q4 2022 | Oct 31, 2022 | — | $0.01 | — | — |
Q3 2022 | Jul 26, 2022 | — | $-0.03 | — | — |
Q2 2022 | May 31, 2022 | — | $-0.02 | — | — |
Q4 2021 | Nov 30, 2021 | — | $-0.03 | — | — |
Q4 2021 | Oct 28, 2021 | — | $-0.04 | — | — |
Q3 2021 | Aug 31, 2021 | — | $-0.03 | — | — |
Q1 2021 | Feb 28, 2021 | — | $-0.06 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ENBI.CN
What is ENBI.CN's current stock price?
Entheon Biomedical Corp. (ENBI.CN) is currently trading at $0.10 per share. The stock has moved +0.00% today.
What is the analyst price target for ENBI.CN?
No analyst price targets are currently available for this stock.
What sector is Entheon Biomedical Corp. in?
Entheon Biomedical Corp. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the CNQ exchange.
What is ENBI.CN's market cap?
Entheon Biomedical Corp. has a market capitalization of $0.00 billion, making it a small-cap company.
Does ENBI.CN pay dividends?
No, Entheon Biomedical Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCPTR.CN
Captor Capital Corp.
$0.28
Mkt Cap: $0.0B
CRCC.CN
Copland Road Capital Corporation
$0.13
Mkt Cap: $0.0B
IBO.V
Universal Ibogaine Inc.
$0.01
Mkt Cap: $0.0B
MOOD.CN
Doseology Sciences Inc.
$0.64
Mkt Cap: $0.0B
OVAT.CN
Ovation Science Inc.
$0.04
Mkt Cap: $0.0B
PHA.V
Premier Health of America Inc.
$0.03
Mkt Cap: $0.0B
TILT.NE
TILT Holdings Inc.
$0.01
Mkt Cap: $0.0B
TMED.CN
EGF Theramed Health Corp.
$0.07
Mkt Cap: $0.0B
VXL.V
Vaxil Bio Ltd.
$0.13
Mkt Cap: $0.0B
XTRX.CN
Adastra Holdings Ltd.
$0.23
Mkt Cap: $0.0B
Explore stocks similar to ENBI.CN for comparison